Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial

Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:41:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous v3.4.1. This appears to be a minor metadata update with no substantive changes to the study content or displayed information.
    Difference
    0.1%
    Check dated 2026-02-13T07:45:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no visible changes to page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:33:43.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Minor UI and metadata updates: added the glossary toggle label, standardized capitalization for QC criteria labels, updated No FEAR Act data labeling, and versioned the revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:52:54.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated to v3.3.4, replacing v3.3.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-01-15T02:47:10.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section listing Texas as a site, while the prior Texas Locations heading was removed. The HHS Vulnerability Disclosure link was removed and the revision version updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T15:09:19.000Z thumbnail image

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.